No Data
No Data
Tharimmune Abandons Acquisition of Intract Pharma
Express News | Tharimmune Inc - Increases Board Size to Six
What's Going On With Tharimmune Shares Monday?
Express News | Tharimmune Shares Are Trading Higher After the Company Announced It Will Present at the 75th AASLD Liver Meeting
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Tharimmune Granted Patent for Delivery of Molecularly Targeted Therapeutics
No Data
No Data